GE HealthCare Technologies Inc.
For the period ended Jun 30, 2026. Filed Jul 29, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Jul 29, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Results of Operations – Segments
We exclude from Segment EBIT certain corporate-related expenses and certain transactions or adjustments that our Chief Operating Decision Maker considers to be non-operational, such as Interest and other financial charges – net, Benefit (provision) for income taxes, restructuring costs, acquisition and disposition-related benefits (charges), Spin-Off and separation costs and other adjustments, Non-operating benefit (income) costs, gain (loss) on business and asset dispositions, amortization of acquisition-related intangible assets, Net (income) loss attributable to noncontrolling interests, Income (loss) from discontinued operations, net of taxes, investment revaluation gain (loss), and other non-recurring items such as refunds for tariffs incurred in prior years. See Note 3, “Segment Information” for additional information on our reportable segments, and “Results of Operations” above for discussion on segment revenue performance.
| Segment EBIT | For the three months ended June 30 | For the six months ended June 30 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | % of segment revenues | 2025 | % of segment revenues | % change | 2026 | % of segment revenues | 2025 | % of segment revenues | % change | |
| AIS | $525 | 13.9% | $455 | 13.0% | 15.4% | $1,004 | 13.5% | $914 | 13.3% | 9.8% |
| PDx | 250 | 29.6% | 213 | 29.3% | 16.9% | 446 | 27.7% | 418 | 30.7% | 6.7% |
| PCS | (26) | (3.8)% | 60 | 7.7% | (143.0)% | (16) | (1.2)% | 108 | 7.0% | (114.8)% |
AIS Segment EBIT was $525 million, an increase of $70 million due to a growth in sales volume and an increase in price, partially offset by cost inflation. The impact of incremental year-over-year tariff expense was offset by tariff refunds relating to 2026;
PDx Segment EBIT was $250 million, an increase of $36 million due to a growth in sales volume and an increase in price, partially offset by planned investments; and
PCS Segment EBIT was $(26) million, a decrease of $85 million due to a decline in sales volume and cost inflation.
AIS Segment EBIT was $1,004 million, an increase of $89 million due to a growth in sales volume and contract settlements, partially offset by cost inflation, including the impact of incremental tariffs;
PDx Segment EBIT was $446 million, an increase of $28 million due to a growth in sales volume and an increase in price, partially offset by a now resolved supplier issue and planned investments; and
PCS Segment EBIT was $(16) million, a decrease of $124 million due to a decline in sales volume and cost inflation.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.